BACKGROUND: Somatic mutation in the X-linked phosphatidylinositol glycan class A gene (PIG-A) causes glycosyl phosphatidylinositol anchor deficiency in human patients with paroxysmal nocturnal hemoglobinuria. DESIGN AND METHODS: We produced an animal model of paroxysmal nocturnal hemoglobinuria by conditional Pig-a gene inactivation (Pig-a(-/-)) in hematopoietic cells; mice carrying two lox sites flanking exon 6 of the Pig-a gene were bred with mice carrying the transgene Cre-recombinase under the human c-fes promoter. We characterized the phenotypic and functional properties of glycosyl phosphatidylinositol-deficient and glycosyl phosphatidylinositol-normal hematopoietic cells from these Pig-a(-/-) mice using gene expression microarray, flow cytometry, bone marrow transplantation, spectratyping, and immunoblotting. RESULTS: In comparison to glycosyl phosphatidylinositol-normal bone marrow cells, glycosyl phosphatidylinositol-deficient bone marrow cells from the same Pig-a(-/-) animals showed up-regulation of the expression of immune function genes and contained a significantly higher proportion of CD8 T cells. Both characteristics were maintained when glycosyl phosphatidylinositol-deficient cells were transplanted into lethally-irradiated recipients. Glycosyl phosphatidylinositol-deficient T cells were inactive, showed pronounced Vbeta5.1/5.2 skewing, had fewer gamma-interferon-producing cells after lectin stimulation, and contained fewer CD4(+)CD25(+)FoxP3(+) regulatory T cells. However, the levels of T-cell receptor signaling proteins from glycosyl phosphatidylinositol-deficient cells were normal relative to glycosyl phosphatidylinositol-normal cells from wild type animals, and cells were capable of inducing target cell apoptosis in vitro. CONCLUSIONS: Deletion of the Pig-a gene in hematopoietic cells does not cause frank marrow failure but leads to the appearance of clonally-restricted, inactive yet functionally competent CD8 T cells.
BACKGROUND: Somatic mutation in the X-linked phosphatidylinositol glycan class A gene (PIG-A) causes glycosyl phosphatidylinositol anchor deficiency in humanpatients with paroxysmal nocturnal hemoglobinuria. DESIGN AND METHODS: We produced an animal model of paroxysmal nocturnal hemoglobinuria by conditional Pig-a gene inactivation (Pig-a(-/-)) in hematopoietic cells; mice carrying two lox sites flanking exon 6 of the Pig-a gene were bred with mice carrying the transgene Cre-recombinase under the human c-fes promoter. We characterized the phenotypic and functional properties of glycosyl phosphatidylinositol-deficient and glycosyl phosphatidylinositol-normal hematopoietic cells from these Pig-a(-/-) mice using gene expression microarray, flow cytometry, bone marrow transplantation, spectratyping, and immunoblotting. RESULTS: In comparison to glycosyl phosphatidylinositol-normal bone marrow cells, glycosyl phosphatidylinositol-deficient bone marrow cells from the same Pig-a(-/-) animals showed up-regulation of the expression of immune function genes and contained a significantly higher proportion of CD8 T cells. Both characteristics were maintained when glycosyl phosphatidylinositol-deficient cells were transplanted into lethally-irradiated recipients. Glycosyl phosphatidylinositol-deficient T cells were inactive, showed pronounced Vbeta5.1/5.2 skewing, had fewer gamma-interferon-producing cells after lectin stimulation, and contained fewer CD4(+)CD25(+)FoxP3(+) regulatory T cells. However, the levels of T-cell receptor signaling proteins from glycosyl phosphatidylinositol-deficient cells were normal relative to glycosyl phosphatidylinositol-normal cells from wild type animals, and cells were capable of inducing target cell apoptosis in vitro. CONCLUSIONS: Deletion of the Pig-a gene in hematopoietic cells does not cause frank marrow failure but leads to the appearance of clonally-restricted, inactive yet functionally competent CD8 T cells.
Authors: M Tarutani; S Itami; M Okabe; M Ikawa; T Tezuka; K Yoshikawa; T Kinoshita; J Takeda Journal: Proc Natl Acad Sci U S A Date: 1997-07-08 Impact factor: 11.205
Authors: A L Burkhardt; B Stealey; R B Rowley; S Mahajan; M Prendergast; J Fargnoli; J B Bolen Journal: J Biol Chem Date: 1994-09-23 Impact factor: 5.157
Authors: D E Dunn; J Yu; S Nagarajan; M Devetten; F F Weichold; M E Medof; N S Young; J M Liu Journal: Proc Natl Acad Sci U S A Date: 1996-07-23 Impact factor: 11.205
Authors: A Rawstron; S Barrans; D Blythe; F Davies; A English; G Pratt; A Child; G Morgan; A Jack Journal: Br J Haematol Date: 1999-01 Impact factor: 6.998
Authors: I Stefanová; M W Saville; C Peters; F R Cleghorn; D Schwartz; D J Venzon; K J Weinhold; N Jack; C Bartholomew; W A Blattner; R Yarchoan; J B Bolen; I D Horak Journal: J Clin Invest Date: 1996-09-15 Impact factor: 14.808
Authors: B Hertenstein; B Wagner; D Bunjes; C Duncker; A Raghavachar; R Arnold; H Heimpel; H Schrezenmeier Journal: Blood Date: 1995-08-15 Impact factor: 22.113
Authors: Tae-Hoon Shin; Eun Jung Baek; Marcus A F Corat; Shirley Chen; Jean-Yves Metais; Aisha A AlJanahi; Yifan Zhou; Robert E Donahue; Kyung-Rok Yu; Cynthia E Dunbar Journal: Blood Date: 2019-04-19 Impact factor: 22.113
Authors: Miguel Rodríguez de Los Santos; Marion Rivalan; Friederike S David; Alexander Stumpf; Julika Pitsch; Despina Tsortouktzidis; Laura Moreno Velasquez; Anne Voigt; Karl Schilling; Daniele Mattei; Melissa Long; Guido Vogt; Alexej Knaus; Björn Fischer-Zirnsak; Lars Wittler; Bernd Timmermann; Peter N Robinson; Denise Horn; Stefan Mundlos; Uwe Kornak; Albert J Becker; Dietmar Schmitz; York Winter; Peter M Krawitz Journal: Proc Natl Acad Sci U S A Date: 2021-01-12 Impact factor: 11.205